Epstein Index›Documents›EFTA00633452
💨IMPACT LEVEL 1 — MEH

Epstein File EFTA00633452: Pilot, Hanging and Targeted (DS9)

General DocumentDate unavailableEFTA006334521 keyword hits
1
views
0
shares
0
reactions
0
persons
3
keywords
4
excerpts

This document discusses a pilot program established in January 2011 between Foundation Medicine and Novartis, an expanded three-year agreement in June 2012, and targeted therapy clinical development efforts for pediatric cancers. The document appears to be general pharmaceutical or medical research material with no apparent connection to the Epstein case.

👤 Named in This Document
No named persons linked yet
🔑 Evidence Keywords

📋 Key Excerpts4

PersonKeyword
Excerpt 1
As the result of Foundation Medicine and Novartis' **pilot** program established in January 2011 and an expanded three-year agreement in June 2012, Foundation
Excerpt 2
And yet stock value is **hanging** around 23.
Excerpt 3
Novartis uses these capabilities to support its **targeted** therapy EFTA00633452 clinical development efforts by helping to align the genomic profile of

Discussion

Let the world know how you feel.

What you just read should make you angry. Channel that into 17 syllables. Our AI helps you craft a haiku in seconds — then share it with the world.

Power hides in dark But sunlight finds every crack Truth cannot be bought

— Sarah K., after reading this document
✍️ Write Your Haiku

Haikus for Humanity — 5 · 7 · 5

React
Share𝕏🦋FBinFund Accountability